HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 15 April 2019

March’s CEAs.....

We’ve completed our quick search for CEA’s published last month.   In the right-hand column of this blog is a CEA Archive of all records.  Below are those in our areas of interest.
  • Berkovits SM, Alvero AM. The Effects of Monetary Incentives on Planned and Unplanned Absences in Adolescent Part-Time Employees: a Cost-Effectiveness Analysis. Behavior analysis in practice. 2019;12(1):162-6.
  • Chomsky-Higgins K, Kahn JG. Interventions and Innovation to Prevent Surgical Site Infection in Colorectal Surgery: A Cost-Effectiveness Analysis. The Journal of surgical research. 2019;235:373-82.
  • Gomes M, Pennington M, Black N, Smith S. Cost-effectiveness analysis of English memory assessment services 2 years after first consultation for patients with dementia. International journal of geriatric psychiatry. 2019;34(3):439-46.
  • Jendle J, Pohlmann J, de Portu S, Smith-Palmer J, Roze S. Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes. Diabetes technology & therapeutics. 2019;21(3):110-8.
  • Phi XA, Greuter MJW, Obdeijn IM, Oosterwijk JC, Feenstra TL, Houssami N, et al. Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis. Breast (Edinburgh, Scotland). 2019;45:82-8.
  • Tew M, Clarke P, Thursky K, Dalziel K. Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer Patients. PharmacoEconomics. 2019.

Posted by at